Market Overview

Benzinga's Top Upgrades

Related MYL
Teva's Nuvigil Patent Infringement Lawsuits Resolved - Analyst Blog
Wells Fargo Initiates Coverage On The Pharmaceutical Space
Pfizer Loses Bid to Hold Celebrex Exclusivity to '15 (Fox Business)
Related SHLM
PolyOne's ECCOH Drives Performance of LEONI's Cables - Analyst Blog
​Mid-Afternoon Market Update: Facebook To Buy LiveRail; Greenbrier Surges

Analysts at Canaccord upgraded Mylan (NASDAQ: MYL) from “hold” to “buy.” Mylan's shares closed at $25.00 yesterday. Mylan's trailing-twelve-month ROE is 15.70%.

Analysts at Longbow upgraded A. Schulman (NASDAQ: SHLM) from “underperform” to “neutral.” A. Schulman's shares closed at $25.14 yesterday. A. Schulman's PEG ratio is 0.79.

Analysts at Benchmark upgraded Expedia (NASDAQ: EXPE) from “hold” to “buy.” Expedia's stock closed at $51.25 yesterday. Expedia's trailing-twelve-month operating margin is 14.22%.

Analysts at RBC Capital upgraded PulteGroup (NYSE: PHM) from “sector perform” to “outperform.” PulteGroup's shares closed at $17.01 yesterday. PulteGroup's trailing-twelve-month revenue is $4.35 billion.

Posted-In: top upgradesUpgrades Analyst Ratings


Most Popular

Related Articles (EXPE + MYL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free